Innovative Vaccine and Immunization Funding: Advance Market Commitments

Maram Ahmed ()
Additional contact information
Maram Ahmed: School of Oriental and African Studies

Chapter Chapter 3 in Innovative Humanitarian Financing, 2021, pp 29-63 from Palgrave Macmillan

Abstract: Abstract One of the top infectious disease killers of children under the age of five globally is pneumonia, with most mortality occurring in low and middle-income countries. Vaccines are considered to be important for public health and an effective tool to reduce preventable deaths, for example, pneumococcal conjugate vaccines (PCVs) have helped reduce severe childhood pneumonia and other pneumococcal diseases. However, the market for and the development of vaccines targeting diseases in developing countries has been disproportionately slow. This chapter will evaluate the effectiveness of innovative health financing sources in particular, advance market commitments, as viable funding mechanisms for global health initiatives such as vaccine and immunization programs through a case study of the Pneumococcal Vaccine Advance Market Commitment Program and more specifically, the development of the 10-valent pneumococcal conjugate vaccine.

Date: 2021
References: Add references at CitEc
Citations:

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:pal:psifcp:978-3-030-83209-4_3

Ordering information: This item can be ordered from
http://www.palgrave.com/9783030832094

DOI: 10.1007/978-3-030-83209-4_3

Access Statistics for this chapter

More chapters in Palgrave Studies in Impact Finance from Palgrave Macmillan
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().